6,225 results match your criteria: "Oncolytic Viruses"

S
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Taha Azad, Reza Rezaei, Ragunath Singaravelu, Adrian Pelin, Stephen Boulton

Nat Commun· May 2023

Videos about Article: user user

2 9 2

View All Article and Social Media Activity
E
Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research.
Pooya Faranoush, Alireza Jahandideh, Reza Nekouian, Pejman Mortazavi

Vet Med Sci· May 2023

Videos about Article: user

1 1 1 9

View All Article and Social Media Activity
I
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
Brendan D Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries

J Immunother Cancer· December 2022

Videos about Article: user

1 15

View All Article and Social Media Activity
T
The HYAL1 paradox in cancer: From complex tumor biology to novel therapeutic strategies.
Yun Jin, Tongyu Wang, Junyan Ma, Jiao Quan, Ning Zhou

Transl Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review).
Shiwen Bi, Tiyan Shan, Yong Tang, Qi Wang

Int J Oncol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.
Masaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, Yu Mikane, Shunya Hanzawa

Cancer Immunol Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Exposure and Immune-Related Cutaneous Adverse Events During Immune Checkpoint Blockade Therapy.
Lukas Kraehenbuehl, Stephanie Gu, Jessica A Lavery, Sara Chekalil, Kwami F Ketosugbo

JAMA Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering HSV-1 for oncolytic therapy: From molecular entry mechanisms to retargeting strategies.
Yufang Zou, Juan Tao, Yingzheng Gao, Jixuan Wang, Pengfei Wang

Genes Dis· March 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential strategies to improve the therapeutic efficacy of oncolytic viruses for cancer through T and NK cells targeting.
Chuanjian Wu, Hanzhang Liu, Yujie Shi, Jie Tang, Rong Sun

Crit Rev Oncol Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation.
Zhendong Wu, Xuefei Fu, Yuan Feng, Rong Zeng, Huan Qin

Cancer Biol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits.
Frederik Radvan, Alexandra Hauser, Li-Yun Lin, Sarah Wilmschen-Tober, Marion Schaber

NPJ Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
Joseph W Jackson, Bonnie L Hall, Chaim Sneiderman, Amy Webb, Trevor J Hancock

Mol Ther Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma.
Alireza Azani, Vahid Ghassemifar, Zahra Mehrdad, Maryam Saberivand, Anahid Bagheripour

Cancer Rep (Hoboken)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial genome engineering of pseudorabies virus Bartha by developing a reverse genetic system based on three overlapping genomic segments.
Hengxing Yuan, Yulu Zhang, Long Tan, Yue Yang, Ji Luan

J Adv Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing glioblastoma immunotherapy: Molecular pathways and innovative therapeutic strategies.
Min Tang, Pengpeng Xu, Xiaogang Zhang

Pathol Res Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Oncolytic viruses influence the biogenesis and immunogenicity of tumor-derived extracellular vesicles].
Ugo Hirigoyen, Nicolas Boisgerault

Med Sci (Paris)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies and innovation for recurrent high-grade glioma.
Jan Drappatz, Megan Mantica

J Neurooncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Cassandra Catacalos-Goad, Dakota W Goad, Molly C Holbrook, Quinton Krueger, Isha M Wilson

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy.
Zujian Hu, Yining Sun, Shenlei Yu, Fan Zheng, Zhuo Yan

Mater Today Bio· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for glioblastoma.
Zouina Sarfraz, Tulika Ranjan, Fatma Nihan Akkoc Mustafayev, Manuela Jaramillo, Yazmin Odia

J Neurooncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of oncolytic adenovirus YSCH-01 in osteosarcoma evaluated in PDX and CDX mouse models.
Hanqiang Jin, Ruoyu Chen, Yonggang Wang, Jin Huang, Xue-Ping Cao

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells.
C A Iannuzzi, F Pagano, M Tomeo, A Sfera, A Calabrese

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and targeted therapy for high grade gliomas: current and future directions.
Brian Hsueh, Samuel J Steuart, Angel O Odukoya, Briana C Prager, Young Joon Kim

J Neurooncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration.
Lee S Rosen, Christian Ottensmeier, Maria Hawkins, Aung Naing, Guru Sonpavde

J Immunother Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Local and systemic combination therapy: endoscopic injection of an oncolytic virus with PD-1 inhibitor for an elderly patient with advanced gastrointestinal cancer.
Siqi Luo, Xue Ding, Hong Zhang, Li Dai, Meifeng Zhang

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Microbe-Mediated Macrophage Education: A Novel Paradigm in Cancer Immunotherapy.
Rongwei Xu, Xinyuan Zhao, Xu Chen, Huixi Zhou, Li Cui

Biomater Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Reovirus-Induced Prostaglandin E2 Production in Human Tumor Cells.
Ikuho Ishigami, Hiroaki Shimada, Ayaka Ihara, Atsushi Kawase, Hiroyuki Mizuguchi

Biol Pharm Bull· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy.
Federico Giovannoni, Craig A Strathdee, Camilo Faust Akl, Brian M Andersen, Zhaorong Li

Nat Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-8-Induced Tumor Self-Rampart Spatially Confines Oncolytic Virotherapy in Glioblastoma.
Shan Jiang, Houshi Xu, Maoyuan Sun, Yongfen Xu, Huihui Chai

Neuro Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of non-cancer cell infections in oncolytic virus therapy.
Jahanara Rajwani, Douglas J Mahoney

Semin Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis